Vera Therapeutics appoints Christy Oliger to board; grants 25K share options

Vera Therapeutics, Inc.

Christy Oliger appointed as Class III Director effective June 7, 2024, term through 2027 annual meeting.
Received nonstatutory stock option for 25,000 shares vesting monthly over three years.
Annual cash retainer of $40,000 for board service plus $4,000 for Nominating Committee, prorated for 2024.
Awarded 2,987 restricted stock units, fully vested for prior consulting services, settling in 2025.
Will serve on Nominating and Corporate Governance Committee.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Christy Oliger

Director

VERA · Vera Therapeutics, Inc.

Effective: 2024-06-07
Filed: June 12, 2024, 7:59 PM ET

On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Christy Oliger was appointed as Director at Vera Therapeutics, Inc..

Action: appointed
Role: Director

Exact text from the filing

On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.

View on SEC.gov

Vera Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-159935

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.